A detailed history of Rothschild Investment LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 100 shares of ARWR stock, worth $2,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 45 122.22%
Holding current value
$2,105
Previous $1.17 Million 65.56%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$19.36 - $29.54 $1,064 - $1,624
55 Added 122.22%
100 $1.94 Million
Q2 2024

Jul 30, 2024

BUY
$21.87 - $28.24 $984 - $1,270
45 New
45 $1.17 Million
Q1 2024

Jul 31, 2024

SELL
$27.21 - $39.48 $952 - $1,381
-35 Reduced 77.78%
10 $286,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.23B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.